Syringe dead space (revision 28)
Old revision·10:01, 30 Nov 2025·TrialsTabitha
| Syringe dead spaceResidual volume | |
|---|---|
Dead space lies distal to the plunger tip at full depression: the hub cavity, the needle lumen and any recess in the plunger face. | |
| Also known as | Residual volume; hold-up volume; wastage volume |
| Location | Needle hub, needle lumen, plunger-tip recess |
| Reported magnitude | 0.002–0.100 mL depending on configuration |
| Dominant contributor | Hub cavity, not the needle lumen |
| Representative volumes | |
| Insulin syringe, permanently attached needle | ≈0.002–0.006 mL |
| 1 mL syringe, Luer slip plus 25G needle | ≈0.070 mL |
| 3 mL syringe, Luer lock plus 21G needle | ≈0.080–0.100 mL |
| Low-dead-space needle on a Luer hub | ≈0.010 mL |
| Applicable standards | |
| Hypodermic syringes | ISO 7886-1 |
| Insulin syringes | ISO 8537 |
| Hypodermic needles | ISO 7864 |
| Needle tubing dimensions | ISO 9626 |
| Delivered-volume tolerance at nominal capacity | ±5% (ISO 7886-1) |
| Topic infobox · conventions | |
Syringe dead space is the volume of liquid that remains inside a syringe and its needle after the plunger has been fully depressed. It occupies the cavity of the needle hub, the lumen of the needle itself and any recess in the face of the plunger tip, and it is not delivered to the injection site.[1]
The quantity matters for two distinct reasons that are frequently conflated. First, the retained liquid is discarded with the device, so each injection consumes the nominal dose plus the dead-space volume; over the life of a reconstituted vial this reduces the number of doses obtainable. Second, if the dead space is occupied by air rather than liquid at the moment the plunger position is read against the graduations, and that air is subsequently expelled, the volume actually delivered is smaller than the volume indicated. The first effect is a wastage problem and does not alter the delivered dose; the second is a dose error and can be large.[2]
Magnitudes vary across almost two orders of magnitude between device types. A 1 mL insulin syringe with a permanently attached fine needle has a dead space of a few microlitres, because the plunger tip enters the needle hub and displaces almost all of it. A general-purpose syringe with a detachable needle on a Luer fitting retains of the order of 70–100 µL, most of it in the hub rather than in the needle.[1][3]
Because doses of reconstituted peptides are frequently in the range 0.05–0.30 mL, dead space of 0.07 mL is not a marginal quantity in this context: it is comparable to the dose. The choice of device therefore has arithmetic consequences that a dose expressed in milligrams conceals.[4]
Anatomy and terminology
[edit]A hypodermic syringe delivers liquid by advancing a plunger through a graduated barrel. The graduations relate to the position of the plunger tip, so the volume expelled is the barrel volume swept between the starting and finishing plunger positions. Any volume distal to the plunger tip at full depression is outside that swept volume and is retained.
Three cavities contribute:
- the hub, the conical or cylindrical space between the end of the barrel and the proximal end of the needle cannula, which in a Luer fitting is a substantial void;
- the needle lumen, the bore of the cannula itself;
- the plunger-tip recess, any concavity in the elastomeric or moulded tip that is not filled by the barrel end when fully advanced.
Terminology in the literature is inconsistent. Dead space, dead volume, residual volume and hold-up volume are all used for the same quantity, and residual volume is also used in a different sense for liquid left in the source container after withdrawal. The two are separate: the liquid left in a vial because the needle cannot reach it, or because the vial geometry traps it, is a container property and is discussed at underfilling and at vial. This article uses dead space for the syringe-and-needle quantity only.[5]
The distinction between high dead-space and low dead-space devices entered the literature through injecting-drug-use epidemiology, where the retained volume determines how much blood a shared syringe can transfer. Low-dead-space designs achieve their reduction either by moulding the needle permanently into a plunger-penetrable hub, or by fitting a plastic insert into an otherwise standard Luer hub so that the plunger tip advances into it.[3]
Measured and computed magnitudes
[edit]Published measurements are made gravimetrically: the assembled device is filled, fully discharged, and the retained mass determined by weighing, with density assumed. Values below are representative of those reported in the injection-equipment literature and vary between manufacturers of nominally equivalent devices.[1][3]
| !Configuration | Dead space | Dominant cavity |
|---|---|---|
| 1 mL insulin syringe, permanently attached 29–31G needle | 0.002–0.006 mL | Plunger-tip recess |
| 1 mL syringe, Luer slip, 25G × 16 mm detachable needle | ≈0.070 mL | Hub |
| 3 mL syringe, Luer lock, 21G × 25 mm detachable needle | 0.080–0.100 mL | Hub |
| Luer hub with no needle fitted | ≈0.060 mL | Hub |
| Low-dead-space insert needle on a Luer hub | ≈0.010 mL | Residual hub void |
The consistent finding is that the hub dominates. This is counter-intuitive, because the needle is the visibly narrow and visibly long component, but the arithmetic is unambiguous once the lumen volume is computed from tubing dimensions.[6]
| !Gauge | Nominal outside diameter | Typical inside diameter | Lumen volume |
|---|---|---|---|
| 18G | 1.270 mm | 0.838 mm | 7.00 µL |
| 21G | 0.819 mm | 0.514 mm | 2.64 µL |
| 23G | 0.641 mm | 0.337 mm | 1.13 µL |
| 25G | 0.515 mm | 0.260 mm | 0.67 µL |
| 27G | 0.413 mm | 0.210 mm | 0.44 µL |
| 29G | 0.337 mm | 0.184 mm | 0.34 µL |
| 30G | 0.312 mm | 0.159 mm | 0.25 µL |
| 31G | 0.261 mm | 0.133 mm | 0.18 µL |
Volumes are computed as the product of cross-sectional area and length; outside diameters follow the metric equivalents of the Birmingham gauge series used in ISO 9626, and inside diameters are typical regular-wall values.[6] A 27G half-inch needle therefore holds 0.44 µL, roughly one part in 160 of a 70 µL hub. Changing needle gauge or length has almost no effect on dead space; changing the hub design changes it by an order of magnitude.
Effect of needle length
[edit]Doubling cannula length from 12.7 mm to 25.4 mm doubles the lumen volume, taking a 25G needle from 0.67 to 1.34 µL. Against a hub of 60–70 µL this is immaterial. Needle length is selected on anatomical grounds — 4, 6 and 8 mm pen needles and 12.7 mm syringe needles are the common lengths for subcutaneous administration — and not on dead-space grounds.[7]
Consequences for delivered dose and for vial yield
[edit]The two consequences are separable and are treated separately here because the distinction is the most common error in secondary discussion of the topic.
Wastage. When a syringe is filled by drawing liquid through the needle, the hub and lumen fill first and remain full. Setting the plunger tip to a graduation then places the nominal volume in the barrel in addition to the dead-space volume already drawn. Full depression delivers the barrel volume — the dose is correct — and discards the dead-space volume with the device. The loss is to vial yield, not to the dose.
Dose error. If an air pocket equal to the dead space sits in the hub when the graduation is read, the barrel contains that much less liquid than the graduation indicates. Expelling the air before injection then leaves a shortfall equal to the air volume. The proportional error is the dead-space volume divided by the intended dose.
A worked case. A vial containing 5.0 mg of peptide is reconstituted with 2.00 mL of diluent, giving 2.50 mg·mL⁻¹. An intended dose of 0.50 mg corresponds to 0.20 mL.
- With a device of 0.070 mL dead space and an unexpelled hub air pocket of that size, the liquid delivered is 0.20 − 0.07 = 0.13 mL, containing 0.325 mg. The shortfall is 35% of the intended dose.
- With the same device correctly primed and free of air, 0.20 mL and 0.50 mg are delivered, and 0.070 mL — 0.175 mg — is discarded in the device.
- For a smaller intended dose of 0.05 mL, the same 0.070 mL dead space exceeds the dose entirely; no plunger position can deliver 0.05 mL if that volume of air must first be displaced from the hub.
The vial-yield arithmetic follows from the wastage figure. Each dose consumes 0.20 mL delivered plus 0.070 mL retained, or 0.270 mL. From 2.00 mL, seven full doses can be drawn (7 × 0.270 = 1.89 mL), with 0.11 mL remaining — insufficient for an eighth. The nominal ten doses have become seven, a 30% reduction. With a fixed-needle insulin syringe at 0.005 mL, each dose consumes 0.205 mL and nine full doses can be drawn, with 0.155 mL remaining.[4]
Priming and air management
[edit]The mechanism by which the dose error arises is the presence of gas where liquid is assumed. Descriptions of injection technique in manufacturers' prescribing information and in nursing references accordingly treat expulsion of air before the dose is measured as a defined step, and treat the graduation as valid only for a gas-free barrel and hub.[8]
Two configurations make the error more likely. A detachable needle attached after the barrel has been filled introduces a hub full of air that must then be displaced. Reconstitution performed with one needle and injection with another — a common arrangement, since a wider gauge is easier to use for withdrawal — reintroduces an air-filled hub at the point of exchange. Neither is inherently unsafe, but both place the burden of correctness on a step that is easy to omit and whose omission is not visible afterwards.[2]
See also
- Insulin syringe
- Subcutaneous injection
- Reconstitution of lyophilised peptides
- Insulin syringe unit conversion
- Reconstitution calculator
References
- ^ a b c Zule WA, Bobashev G. "High dead-space syringes and the risk of HIV and HCV infection among injecting drug users." Drug and Alcohol Dependence 100(3):204–213 (2009).
- ^ a b Strauss K, van Zundert A, Frid A, Costigliola V. "Pandemic influenza preparedness: the critical role of the syringe." Vaccine 24(24):4874–4882 (2006).
- ^ a b c Zule WA, Cross HE, Stover J, Pretorius C. "Are major reductions in new HIV infections possible with people who inject drugs? The case for low dead-space syringes in highly affected countries." International Journal of Drug Policy 24(1):1–7 (2013).
- ^ a b PeptidePedia community device-measurement tally, 2026 (self-reported, uncalibrated balances, protocol not controlled; weak evidence — see Project:Sourcing guidelines).
- ^ ISO 7886-1:2017, Sterile hypodermic syringes for single use — Part 1: Syringes for manual use. International Organization for Standardization.
- ^ a b ISO 9626:2016, Stainless steel needle tubing for the manufacture of medical devices — Requirements and test methods. International Organization for Standardization.
- ^ ISO 7864:2016, Sterile hypodermic needles for single use — Requirements and test methods. International Organization for Standardization.
- ^ World Health Organization. WHO Guideline on the Use of Safety-Engineered Syringes for Intramuscular, Intradermal and Subcutaneous Injections in Health Care Settings. Geneva (2015).